Laboratory Diagnosis of Congenital Factor V Deficiency, Routine, Specific Coagulation Tests with Molecular Methods
Journal of Cellular & Molecular Anesthesia,
Vol. 1 No. 2 (2016),
16 March 2016
,
Page 87-90
https://doi.org/10.22037/jcma.v1i2.10790
Abstract
Erratum: The correct affiliation of corresponding author of this manuscript has been edited as follows:
"Akbar Dorgalaleh: Department of Hematology and Blood Transfusion, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran."
Factor V (FV) deficiency is a rare bleeding disorder (RBD) that inherit in autosomal recessive manner. Diagnosis of FV deficiency (FVD) is made by routine coagulation tests, FV activity and molecular analysis. In patients with FVD, routine coagulation tests including activated partial thromboplastin time (APTT), prothrombin time (PT) and evenbleeding time (BT) are prolongedwhile thrombin time (TT) is normal. FV activity assay can use for confirmation of diagnosis as well as for differential diagnosis with acquired forms of disease. Mixing study can be used for screening of inhibitor against FV. In this situation, addition of normal plasma cannot correct prolonged PT and PTT while in congenital FVD prolongation is corrected. Molecular diagnosis of FVD is straightforward but due to large size of FV gene and genetic variability molecular diagnosis is restricted to research laboratory.
- Factor V deficiency
- Diagnosis
- rare bleeding disorder
How to Cite
References
Huang J, Koerper M. Factor V deficiency: a concise review. Haemophilia. 2008;14(6):1164-9.
Naderi M, Tabibian S, Dorgalaleh A, Kashani Kahtib Z, Alizadeh S. Public Health Problems related to factor V deficiency in southeast of Iran. Medical journal of the Islamic Republic of Iran. 2014;28:27- 30.
Naderi M, Tabibian S, Alizadeh S, Hosseini S, Zaker F, Bamedi T, et al. Congenital Factor V Deficiency: Comparison of the Severity of Clinical Presentations among Patients with Rare Bleeding Disorders. Acta haematologica. 2015;133(2):148-54.
Thalji N, Camire RM, editors. Parahemophilia: new insights into factor v deficiency. Seminars in thrombosis and hemostasis; 2013.
Asselta R, Tenchini M, Duga S. Inherited defects of coagulation factor V: the hemorrhagic side. Journal of Thrombosis and Haemostasis. 2006;4(1):26-34.
Naderi M, Dorgalaleh A, Tabibian S, Alizadeh S, Eshghi P, Solaimani G. Current understanding in diagnosis and management of factor XIII deficiency. Iranian journal of pediatric hematology and oncology. 2013;3(4):164.
Colman RW, Hirsh J, Marder VJ, Colman, Hirsh, Marder, et al. Hemostasis and thrombosis: basic principles and clinical practice. 2006.
Bolton‐Maggs P, Perry D, Chalmers E, Parapia L, Wilde J, Williams M, et al. The rare coagulation disorders–review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia. 2004;10(5):593-628.
Asselta R, Peyvandi F, editors. Factor V deficiency. Seminars in thrombosis and hemostasis; 2009.
Naderi M, Tabibian S, Hosseini MS, Alizadeh S, Hosseini S, Karami H, et al. Rare bleeding disorders: a narrative review of epidemiology, molecular and clinical presentations, diagnosis and treatment. Journal of Pediatrics Review. 2014;2(2):0-.
Peyvandi F, Palla R, Menegatti M, Mannucci PM, editors. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Seminars in thrombosis and hemostasis; 2009.
Lippi G, Favaloro EJ, Montagnana M, Manzato F, Guidi GC, Franchini M. Inherited and acquired factor V deficiency. Blood coagulation & fibrinolysis. 2011;22(3):160-6 13.Duga S, Asselta R, Tenchini ML. Coagulation factor V. The international journal of biochemistry & cell biology. 2004;36(8):1393-9.
- Abstract Viewed: 321 times
- PDF Downloaded: 236 times